Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Markets slip after weak construction data, utilities fall

Fri, 13th Mar 2015 12:03

Stocks in London dipped into the red on Friday morning after data showed an unexpected decline in UK construction output, while utility shares weakened on political uncertainty.The FTSE 100 was down 0.35% at 6,737.10 by midday with SSE and Centrica among the worst performers.Construction output dropped by 2.6% in January after 0.4% growth the month before, surprising analysts who had expected a 1.3% increase. This was the worst fall in over a year.Meanwhile, figures also showed that construction orders were down 2.9% in the fourth quarter of 2014."So there is a very real risk that construction output will contract in the first quarter of 2015 and be a drag on GDP growth, as it was in the fourth quarter of 2014," said economist Howard Archer from IHS Global Insight.The rest of the session is set to be quiet in terms of economic data, with US producer price inflation and consumer confidence figures the only major releases of the day.Utilities weaken, Afren dropsEnergy stocks declined on Friday morning, ahead of the Labour Party conference, during which Ed Miliband is expected to outline plans to cut energy prices if his party wins the General Election. SSE and British Gas owner Centrica were both trading lower.Shares in Afren tumbled after the struggling oil and gas group proposed a debt-for-equity swap with creditors to address its funding needs and recapitalise its capital structure. The company said it "will result in substantial dilution for existing shareholders", and if shareholders don't approve the plan, the company will have no choice but to initiate a sale.Glaxosmithkline edged lower after selling half its stake in former South African associate Aspen Pharmacare for £0.57bn. Having sold 28.2m shares, at a price of 372 rand per share, GSK now holds a 6.2% stake in Aspen, South Africa's largest drug company.JD Wetherspoon served up a slightly short measure of first-half profits as the pubs group saw cost pressures outweigh a rise in revenues. Profits declined 0.9% in the first half while the interim dividend was maintained, causing shares to fall in London.Shares in Premier Inn and Costa owner Whitbread received a boost from UBS which upgraded its rating on the stock from 'sell' to 'neutral' and hiked its target price from 4,700p to 5,400p. Deutsche Bank also lifted its rating on the stock to 'buy'.Spirits group Diageo was shot down by analysts at Credit Suisse as they lowered their recommendation from 'neutral' to 'underperform', saying that the main drivers of earnings growth over the past years each face structural challenges.Market MoverstechMARK 3,175.54 +0.27%FTSE 100 6,737.10 -0.35%FTSE 250 17,088.58 +0.16%FTSE 100 - RisersWhitbread (WTB) 5,375.00p +2.19%British Land Co (BLND) 819.50p +1.80%Meggitt (MGGT) 569.00p +1.70%ARM Holdings (ARM) 1,180.00p +1.55%Coca-Cola HBC AG (CDI) (CCH) 1,123.00p +1.26%ITV (ITV) 252.00p +1.25%Wolseley (WOS) 4,097.00p +1.14%Reckitt Benckiser Group (RB.) 5,775.00p +1.14%GKN (GKN) 366.00p +1.10%Royal Mail (RMG) 430.10p +1.01%FTSE 100 - FallersBG Group (BG.) 819.60p -2.27%SSE (SSE) 1,463.00p -1.88%Centrica (CNA) 236.90p -1.86%Royal Dutch Shell 'B' (RDSB) 2,022.00p -1.51%BHP Billiton (BLT) 1,414.00p -1.50%BP (BP.) 419.55p -1.48%Royal Dutch Shell 'A' (RDSA) 1,933.50p -1.40%Standard Chartered (STAN) 966.00p -1.33%Morrison (Wm) Supermarkets (MRW) 204.90p -1.30%Friends Life Group Limited (FLG) 413.90p -1.29%FTSE 250 - RisersThomas Cook Group (TCG) 156.30p +5.18%Bwin.party Digital Entertainment (BPTY) 83.10p +4.33%Diploma (DPLM) 798.00p +4.25%St. Modwen Properties (SMP) 459.40p +3.94%Allied Minds (ALM) 642.50p +3.71%Home Retail Group (HOME) 180.00p +3.45%Just Eat (JE.) 343.70p +3.34%PayPoint (PAY) 846.00p +3.17%Workspace Group (WKP) 838.00p +3.14%Ocado Group (OCDO) 387.80p +2.84%FTSE 250 - FallersAfren (AFR) 4.80p -26.15%Soco International (SIA) 149.30p -5.86%Cairn Energy (CNE) 152.40p -5.46%Wetherspoon (J.D.) (JDW) 775.00p -4.50%RPS Group (RPS) 230.60p -3.92%Hikma Pharmaceuticals (HIK) 2,263.00p -3.91%Ophir Energy (OPHR) 121.10p -3.35%Vedanta Resources (VED) 512.00p -2.94%Hunting (HTG) 467.90p -2.88%Premier Oil (PMO) 133.50p -2.77%
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.